Literature DB >> 34322727

Ultrasound-guided biopsy of challenging abdominopelvic targets.

Edward M Lawrence1, Meghan G Lubner1, Perry J Pickhardt1, Michael P Hartung2.   

Abstract

Percutaneous ultrasound-guided biopsies have become the standard of practice for tissue diagnosis in the abdomen and pelvis for many sites including liver, kidney, abdominal wall, and peripheral nodal stations. Additional targets may appear difficult or impossible to safely biopsy by ultrasound due to interposed bowel loops/vasculature, deep positioning, association with the bowel, or concern for poor visibility; however, by optimizing technique, it is often possible to safely and efficiently use real-time ultrasound guidance for sampling targets that normally would be considered only appropriate for CT guided or surgical/endoscopic biopsy.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Mesh:

Year:  2021        PMID: 34322727     DOI: 10.1007/s00261-021-03223-4

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  50 in total

1.  Percutaneous liver biopsy: a cost-benefit analysis comparing sonographic and CT guidance.

Authors:  M A Kliewer; D H Sheafor; E K Paulson; R S Helsper; B S Hertzberg; R C Nelson
Journal:  AJR Am J Roentgenol       Date:  1999-11       Impact factor: 3.959

Review 2.  Ultrasound-guided biopsies in the abdomen and pelvis.

Authors:  Thomas C Winter; Fred T Lee; J Louis Hinshaw
Journal:  Ultrasound Q       Date:  2008-03       Impact factor: 1.657

3.  Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience.

Authors:  Hazem El-Osta; David Hong; Jennifer Wheler; Siqing Fu; Aung Naing; Gerald Falchook; Marshall Hicks; Sijin Wen; Apostolia M Tsimberidou; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-08-22

4.  Abdominal percutaneous interventional procedures: comparison of CT and US guidance.

Authors:  D H Sheafor; E K Paulson; C M Simmons; D M DeLong; R C Nelson
Journal:  Radiology       Date:  1998-06       Impact factor: 11.105

5.  Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study.

Authors:  Neema Jamshidi; Danshan Huang; Fereidoun G Abtin; Christopher T Loh; Stephen T Kee; Robert D Suh; Shota Yamamoto; Kingshuk Das; Sarah Dry; Scott Binder; Dieter R Enzmann; Michael D Kuo
Journal:  Radiology       Date:  2016-10-18       Impact factor: 11.105

6.  Determining the Optimal Number of Core Needle Biopsy Passes for Molecular Diagnostics.

Authors:  Nam S Hoang; Benjamin H Ge; Lorraine Y Pan; Michael G Ozawa; Christina S Kong; John D Louie; Rajesh P Shah
Journal:  Cardiovasc Intervent Radiol       Date:  2017-12-26       Impact factor: 2.740

Review 7.  Biopsies: next-generation biospecimens for tailoring therapy.

Authors:  Mark Basik; Adriana Aguilar-Mahecha; Caroline Rousseau; Zuanel Diaz; Sabine Tejpar; Alan Spatz; Celia M T Greenwood; Gerald Batist
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

Review 8.  Contrast-enhanced US-guided Interventions: Improving Success Rate and Avoiding Complications Using US Contrast Agents.

Authors:  Dean Y Huang; Gibran T Yusuf; Mohammad Daneshi; Mohammad Ali Husainy; Raymond Ramnarine; Maria E K Sellars; Paul S Sidhu
Journal:  Radiographics       Date:  2017-03-18       Impact factor: 5.333

9.  Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound.

Authors:  Soon Ho Yoon; Kyoung Ho Lee; So Yeon Kim; Young Hoon Kim; Jee Hyun Kim; Sang Hyub Lee; Tae Kyoung Kim
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

10.  Contrast-Enhanced Ultrasound Guided Biopsy of Undetermined Abdominal Lesions: A Multidisciplinary Decision-Making Approach.

Authors:  Feng Mao; Yi Dong; Zhengbiao Ji; Jiaying Cao; Wen-Ping Wang
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.